Get started
Author

Ana Cristina Vargas

Observed names: A. C. Vargas, A. Cristina Vargas, A.C. Vargas, Ana C Vargas, Ana C. Vargas, Ana Christina Vargas, Ana Cristina, Ana Cristina Vargas Calderon, Cristina Vargas, Vargas, Cristina
Observed institutions: Broad Institute, University of Notre Dame, Brigham and Women's Hospital, The University of Sydney, Harvard University, The University of Queensland, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Royal Prince Alfred Hospital, Royal North Shore Hospital, Princess Alexandra Hospital, Westmead Hospital, Douglass Hanly Moir Pathology, Dana-Farber Cancer Institute, Tisch Cancer Institute, Western Sydney University, The University of Notre Dame Australia, Icahn School of Medicine at Mount Sinai, Macquarie University
ORCID: 0000-0003-3798-5088
Observed ORCIDs: 0000-0003-3798-5088, 0000-0002-9424-2080
OpenAlex ID: A5004851303
The landscape of cancer genes and mutational processes in breast cancer
2012 · Philip J. Stephens, Patrick S. Tarpey, et al. · Nature · 1,741
PDF
SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer
2011 · Marjan E. Askarian-Amiri, Joanna Crawford, et al. · RNA · 340
PDF
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer
2010 · Leonard Da Silva, Peter T Simpson, et al. · Breast Cancer Research · 156
PDF
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
2012 · Ana Cristina Vargas, Amy E. McCart Reed, et al. · Breast Cancer Research and Treatment · 151
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer
2020 · Arcadi Cipponi, David L. Goode, et al. · Science · 106
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
2017 · Rhiannon Coulson, Seng H. Liew, et al. · Oncotarget · 103
PDF
When used together SS18–SSX fusion‐specific and SSX C‐terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases
2020 · Matthew Zaborowski, Ana C Vargas, et al. · Histopathology · 96
In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity
2013 · Chanel E. Smart, Brian J. Morrison, et al. · PLoS ONE · 83
PDF
Treatment of Triple-Negative Breast Cancer Using Anti-EGFR–Directed Radioimmunotherapy Combined with Radiosensitizing Chemotherapy and PARP Inhibitor
2013 · Fares Al-Ejeh, Wei Shi, et al. · Journal of Nuclear Medicine · 80
PDF
Gene expression profiling of formalin‐fixed, paraffin‐embedded familial breast tumours using the whole genome‐DASL assay
2010 · Nic Waddell, Sibylle Cocciardi, et al. · The Journal of Pathology · 68
Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer
2013 · Amy E. McCart Reed, Sarah Song, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 67
Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women
2013 · E. Tilch, T. Seidens, et al. · Breast Cancer Research and Treatment · 59
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients
2021 · Talia L. Fuchs, Fiona Maclean, et al. · Modern Pathology · 58
PDF
NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm
2020 · Daniel D. Wong, Ana Cristina Vargas, et al. · Pathology · 52
An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas
2015 · Amy E McCart Reed, Jamie R Kutasovic, et al. · The Journal of Pathology · 52
PDF
Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
2014 · Fares Al-Ejeh, Mariska Miranda, et al. · Oncotarget · 50
PDF
Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
2018 · Amy E McCart Reed, Jamie R Kutasovic, et al. · The Journal of Pathology · 48
PDF
Expression of MAGE ‐A and NY ‐ ESO ‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers
2018 · Ashwini Raghavendra, Priyakshi Kalita‐de Croft, et al. · Histopathology · 47
PDF
Prevalence of PD-L1 expression in matched recurrent and/or metastatic sarcoma samples and in a range of selected sarcomas subtypes
2020 · Ana Cristina Vargas, Fiona M Maclean, et al. · PLoS ONE · 45
PDF
A Novel E2F/Sphingosine Kinase 1 Axis Regulates Anthracycline Response in Squamous Cell Carcinoma
2014 · Mehlika Hazar-Rethinam, Lilia Merida de Long, et al. · Clinical Cancer Research · 44
RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma
2015 · Mehlika Hazar-Rethinam, Lilia Merida de Long, et al. · Molecular Cancer Therapeutics · 42
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis
2019 · Harvey W. Smith, Alison Hirukawa, et al. · Nature Communications · 39
PDF
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research
2017 · Jodi M. Saunus, Chanel E. Smart, et al. · Breast Cancer Research and Treatment · 38
PDF
Phenotype-Genotype Correlation in Familial Breast Cancer
2011 · Ana Cristina Vargas, Jorge S. Reis-Filho, et al. · Journal of Mammary Gland Biology and Neoplasia · 36
Expression Profiling of Archival Tumors for Long-term Health Studies
2012 · Levi Waldron, Shuji Ogino, et al. · Clinical Cancer Research · 32
Works count: 105
Citation count: 3,958
H-index: 26
I10-index: 38
Year
Topic
Type